| Name | PAX8 antisense RNA 1 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nPAX8‐AS1 is a long noncoding RNA that modulates expression of the transcription factor PAX8 and thereby influences diverse pathological processes. In cervical cancer, specific single nucleotide polymorphisms within PAX8‐AS1 act as expression quantitative trait loci that are associated with a decreased risk of disease."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In breast cancer, a novel isoform—PAX8‐AS1‑N—is activated by baicalein, leading to inhibition of cell viability, induction of apoptosis, and tumor suppression through binding and sequestration of miR‑17‑5p, which in turn upregulates tumor suppressors such as PTEN."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In papillary thyroid carcinoma, reduced expression of PAX8‐AS1 (also termed PAX8‐AS1:28) is associated with increased MYC levels and enhanced tumor cell proliferation, further supporting a tumor‐suppressive role."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Moreover, genetic variants in PAX8‐AS1 have been implicated in non‐Hodgkin lymphoma susceptibility, where certain haplotypes confer decreased risk."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in malignancy, PAX8‐AS1 contributes to non‐cancerous conditions. In diabetic nephropathy, the PAX8‐AS1‑N isoform appears to protect against podocyte apoptosis and is directly associated with the regulation of oxidative stress and angiogenic markers, including VEGF and TGF‑β1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Similarly, in both clinical and subclinical hypothyroidism, decreased serum levels of PAX8‐AS1 along with its genetic variants have been linked to increased disease susceptibility and demonstrate promising potential as diagnostic and prognostic biomarkers."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nEmerging studies have also begun to explore the epigenetic modulation of candidate hypersomnolence genes, including PAX8‐AS1, to elucidate the biological underpinnings of excessive daytime sleepiness and related sleep disorders."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jing Han, Wen Zhou, Meiqun Jia, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression quantitative trait loci in long non-coding RNA PAX8-AS1 are associated with decreased risk of cervical cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Genomics (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00438-016-1217-9"}], "href": "https://doi.org/10.1007/s00438-016-1217-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27225188"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27225188"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Xiaolan Yu, Yong Cao, Li Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Baicalein inhibits breast cancer growth via activating a novel isoform of the long noncoding RNA PAX8-AS1-N."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.26881"}], "href": "https://doi.org/10.1002/jcb.26881"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29693272"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29693272"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Yi Zhang, Feilei Li, Jun Chen "}, {"type": "b", "children": [{"type": "t", "text": "MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2019.6996"}], "href": "https://doi.org/10.3892/or.2019.6996"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30720110"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30720110"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Samaneh Mirzazadeh, Hosna Sarani, Alireza Nakhaee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association between PAX8AS1 (rs4848320 C > T, rs1110839 G > T, and rs6726151 T > G) and MEG3 (rs7158663) gene polymorphisms and non-Hodgkin lymphoma risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleosides Nucleotides Nucleic Acids (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15257770.2022.2104870"}], "href": "https://doi.org/10.1080/15257770.2022.2104870"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35938744"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35938744"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Y Shen, Z-W Tong, Y Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of lncRNA-PAX8-AS1-N directly associated with VEGF/TGF-β1/8-OhdG enhances podocyte apoptosis in diabetic nephropathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_202006_21676"}], "href": "https://doi.org/10.26355/eurrev_202006_21676"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32633379"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32633379"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Omar M Elsayed, Samy A Abdelazim, Hebatallah A Darwish, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of LncRNA-PAX8-AS1 and LAIR-2 polymorphisms along with their expression with clinical and subclinical hypothyroidism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-022-26346-0"}], "href": "https://doi.org/10.1038/s41598-022-26346-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36593237"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36593237"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "David T Plante, Ligia A Papale, Andy Madrid, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PAX8/PAX8-AS1 DNA methylation levels are associated with objective sleep duration in persons with unexplained hypersomnolence using a deep phenotyping approach."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sleep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/sleep/zsab108"}], "href": "https://doi.org/10.1093/sleep/zsab108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34145460"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34145460"}]}]}]}
|
| NCBI Gene ID | 654433 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PAX8-AS1 has 464 functional associations with biological entities spanning 2 categories (cell line, cell type or tissue, gene, protein or microRNA) extracted from 8 datasets.
Click the + buttons to view associations for PAX8-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PAX8-AS1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of PAX8-AS1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PAX8-AS1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PAX8-AS1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PAX8-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PAX8-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PAX8-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PAX8-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |